ICAM2 and stroke disorder: In a proteomics stroke study, researchers identified ICAM-2, STXBP5, PLGLA, C3, and IGHV3-64 as candidate biomarkers in blood, yielding a high (75% to 88%) sensitivity for identifying stroke patients [190].